3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Lung Cancer -

Eczema patients have lowered risk of lung cancer

Lung CancerOct 06, 05

People who’ve had eczema at some time in their lives appear to be less likely than others to develop lung cancer, according to European researchers.

As senior investigator Dr. Paolo Boffetta commented to Reuters Health, a “self-reported history of eczema appears to reduce the risk of lung cancer. These findings might shed light on mechanisms of lung carcinogenesis in humans.”

Boffetta, at the International Agency for Research on Cancer in Lyon, France, and colleagues write in the American Journal of Epidemiology that “persons with a history of eczema have been shown to have a reduced risk of lung cancer, but the evidence has been inconclusive because of the small size of previous studies and their limited ability to control for confounding by smoking,”

To investigate further, the researchers examined data on 2854 people with lung cancer and 3116 matched “controls” recruited between 1998 and 2001 from 16 areas in the Czech Republic, Hungary, Poland, Romania, Russia, Slovakia, and the United Kingdom.

A total of 156 of the lung cancer cases (5 percent) and 275 controls (9 percent) reported a history of eczema. After factoring in age, sex, and cumulative tobacco smoking, a history of eczema reduced the chances of developing lung cancer by 39 percent.

Overall, the researchers conclude that the observed risk reduction “was relatively large and might be of significant clinical importance.”

SOURCE: American Journal of Epidemiology, September 2005.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Profiling approach to enable right lung cancer treatment match
  Pfizer lung cancer drug beats chemo for previously untreated patients
  Moffitt Cancer Center Researchers Find Potential New Therapeutic Target for Treating Non-Small Cell Lung Cancer
  Genome-wide scan maps mutations in deadly lung cancers; reveals embryonic gene link
  Erlotinib improves progression-free survival as first-line therapy in advanced lung cancer
  Lung Cancer Culprit Could Offer Target for Therapy
  Testing lung tumors tailors drug treatments
  In Battle Against Lung Cancer, Investigators Eye Oncolytic Virus Therapy
  Men who eat soy may have lower lung cancer risk
  Lung Cancer Conference Leaders Honor Paul A. Bunn Jr., M.D.
  A new mouse could help understand how some lung cancer cells evade drug treatment
  Tiny RNA has big impact on lung cancer tumors

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site